COMPANY REGISTRATION NUMBER:
15401074
|
C3 BIOTECHNOLOGIES (HYPERSONICS) LIMITED |
|
|
FILLETED UNAUDITED FINANCIAL STATEMENTS |
|
|
C3 BIOTECHNOLOGIES (HYPERSONICS) LIMITED |
|
|
STATEMENT OF FINANCIAL POSITION |
|
30 September 2024
CURRENT ASSETS
|
Debtors |
4 |
100 |
|
----- |
|
NET CURRENT ASSETS |
100 |
|
----- |
|
TOTAL ASSETS LESS CURRENT LIABILITIES |
100 |
|
----- |
|
|
|
CAPITAL AND RESERVES
|
Called up share capital |
100 |
|
----- |
|
SHAREHOLDER FUNDS |
100 |
|
----- |
|
|
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the statement of comprehensive income has not been delivered.
The company did not trade during the period and has not made either a profit or loss.
For the period ending 30 September 2024 the company was entitled to exemption from audit under section 480 of the Companies Act 2006 relating to dormant companies.
Directors' responsibilities:
-
The member has not required the company to obtain an audit of its financial statements for the period in question in accordance with section 476
;
-
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements
.
These financial statements were approved by the
board of directors
and authorised for issue on
20 June 2025
, and are signed on behalf of the board by:
|
Professor N S Scrutton |
|
Director |
|
Company registration number:
15401074
|
C3 BIOTECHNOLOGIES (HYPERSONICS) LIMITED |
|
|
NOTES TO THE FINANCIAL STATEMENTS |
|
PERIOD FROM 9 JANUARY 2024 TO 30 SEPTEMBER 2024
1.
GENERAL INFORMATION
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is 20 Mannin Way, Lancaster Business Park, Caton Road, Lancaster, LA1 3SW.
2.
STATEMENT OF COMPLIANCE
These financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.
3.
ACCOUNTING POLICIES
Basis of preparation
The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.
The financial statements are prepared in sterling, which is the functional currency of the entity.
Income statement
The company is dormant as defined by section 1169 of the Companies Act 2006. The company received no income and incurred no expenditure during the current period.
4.
DEBTORS